Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT05713838
Title Organ Preservation With Durvalumab-based Immunotherapy in Combination With Chemoradiation as Definitive Therapy for Early Stage Esophageal Adenocarcinoma With Indication for Radical Surgery
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Institut fuer Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
Age Groups: adult | senior
Covered Countries DEU

No variant requirements are available.